Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14284 | 714 | 45.9 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
613 | 13260 | 5 HTTLPR//CATECHOL O METHYLTRANSFERASE//COMT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DRD3 | Author keyword | 15 | 39% | 4% | 30 |
2 | T102C POLYMORPHISM | Author keyword | 15 | 88% | 1% | 7 |
3 | TARDIVE DYSKINESIA | Author keyword | 11 | 11% | 12% | 89 |
4 | HTR2A | Author keyword | 9 | 33% | 3% | 21 |
5 | 5 HTR2A | Author keyword | 7 | 67% | 1% | 6 |
6 | 5 HT2A RECEPTOR GENE | Author keyword | 6 | 50% | 1% | 8 |
7 | SEROTONIN 2A RECEPTOR GENE | Author keyword | 5 | 63% | 1% | 5 |
8 | T102C | Author keyword | 5 | 55% | 1% | 6 |
9 | SEROTONIN 2A RECEPTOR | Author keyword | 5 | 24% | 2% | 17 |
10 | D3 RECEPTOR GENE | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DRD3 | 15 | 39% | 4% | 30 | Search DRD3 | Search DRD3 |
2 | T102C POLYMORPHISM | 15 | 88% | 1% | 7 | Search T102C+POLYMORPHISM | Search T102C+POLYMORPHISM |
3 | TARDIVE DYSKINESIA | 11 | 11% | 12% | 89 | Search TARDIVE+DYSKINESIA | Search TARDIVE+DYSKINESIA |
4 | HTR2A | 9 | 33% | 3% | 21 | Search HTR2A | Search HTR2A |
5 | 5 HTR2A | 7 | 67% | 1% | 6 | Search 5+HTR2A | Search 5+HTR2A |
6 | 5 HT2A RECEPTOR GENE | 6 | 50% | 1% | 8 | Search 5+HT2A+RECEPTOR+GENE | Search 5+HT2A+RECEPTOR+GENE |
7 | SEROTONIN 2A RECEPTOR GENE | 5 | 63% | 1% | 5 | Search SEROTONIN+2A+RECEPTOR+GENE | Search SEROTONIN+2A+RECEPTOR+GENE |
8 | T102C | 5 | 55% | 1% | 6 | Search T102C | Search T102C |
9 | SEROTONIN 2A RECEPTOR | 5 | 24% | 2% | 17 | Search SEROTONIN+2A+RECEPTOR | Search SEROTONIN+2A+RECEPTOR |
10 | D3 RECEPTOR GENE | 4 | 75% | 0% | 3 | Search D3+RECEPTOR+GENE | Search D3+RECEPTOR+GENE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLOZAPINE RESPONSE | 64 | 57% | 11% | 75 |
2 | SER9GLY POLYMORPHISM | 54 | 83% | 4% | 30 |
3 | T102C POLYMORPHISM | 49 | 48% | 10% | 74 |
4 | DOPAMINE D3 RECEPTOR | 39 | 48% | 8% | 59 |
5 | 102T C POLYMORPHISM | 26 | 100% | 2% | 11 |
6 | CHINESE SCHIZOPHRENIC PATIENTS | 15 | 67% | 2% | 14 |
7 | 5 HT2A RECEPTOR GENE | 15 | 33% | 5% | 38 |
8 | 5 HT2A RECEPTOR | 15 | 22% | 8% | 60 |
9 | DRD3 | 14 | 64% | 2% | 14 |
10 | MSCI POLYMORPHISM | 14 | 100% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pharmacogenetics of Antipsychotics | 2014 | 9 | 163 | 43% |
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction | 2011 | 50 | 181 | 62% |
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research | 2007 | 187 | 294 | 33% |
The pharmacogenetics of antipsychotic-induced adverse events | 2013 | 15 | 49 | 41% |
HTR2A1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: A meta-analysis | 2013 | 9 | 46 | 54% |
D-2 Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis | 2010 | 43 | 44 | 39% |
Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia | 2011 | 28 | 276 | 46% |
Pharmacogenetics of psychotropic drug response | 2004 | 191 | 127 | 30% |
HTR2A gene variants and psychiatric disorders: A review of current literature and selection of SNPs for future studies | 2007 | 69 | 215 | 44% |
The Pharmacogenetics of Symptom Response to Antipsychotic Drugs | 2012 | 12 | 53 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOMARKER PERSONALIZED MED | 3 | 16% | 2.0% | 14 |
2 | PLICAT PSYCHOL | 1 | 25% | 0.7% | 5 |
3 | PL PHARMACOL MEMBRANE BIOL SIGNAL TRANSDUCT M | 1 | 100% | 0.3% | 2 |
4 | ANAT PATHOL PHARMACOL MICROBIOL | 1 | 17% | 0.8% | 6 |
5 | CLARKE NEUROGENET SECT | 1 | 33% | 0.3% | 2 |
6 | BENJAMIN FRANKLIN UNIV MED | 1 | 50% | 0.1% | 1 |
7 | BK BIOMED SCI 21 | 1 | 50% | 0.1% | 1 |
8 | DISCIPLINE INFORMAT MED BIOSTAT | 1 | 50% | 0.1% | 1 |
9 | EXCELLENCE OMICS NANO MED TECHNOL PROJECT DEV | 1 | 50% | 0.1% | 1 |
10 | GEN PSYCIAT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000214285 | DRD2//REWARD DEFICIENCY SYNDROME RDS//D2 DOPAMINE RECEPTOR GENE |
2 | 0.0000195825 | 5 HTTLPR//SEROTONIN TRANSPORTER GENE//SEROTONIN TRANSPORTER |
3 | 0.0000183903 | ITEM FACTOR MODEL//HOSP BEHAV MED//HAPLOTYPE RELATIVE RISK HRR |
4 | 0.0000124838 | G72//DAOA//MANIC DEPRESSIVE ILLNESS |
5 | 0.0000118928 | DRD4//DAT1//DOPAMINE TRANSPORTER GENE |
6 | 0.0000109603 | AKATHISIA//TARDIVE DYSKINESIA//TARDIVE DYSTONIA |
7 | 0.0000105123 | MPPF//F 18ALTANSERIN//F 18MPPF |
8 | 0.0000085314 | 9 HYDROXYRISPERIDONE//NORCLOZAPINE//PALIPERIDONE |
9 | 0.0000078822 | DOPAMINE D 3 RECEPTOR//D 3 RECEPTOR//7 OH DPAT |
10 | 0.0000070192 | CYP2D6//DEBRISOQUINE//CYP2C19 |